L

Lucid Diagnostics Inc
NASDAQ:LUCD

Watchlist Manager
Lucid Diagnostics Inc
NASDAQ:LUCD
Watchlist
Price: 1.26 USD 2.44% Market Closed
Market Cap: 132.7m USD
Section:
Wall Street Price Targets
Wall Street Price Targets
Revenue Forecast
Operating Income Forecast
Net Income Forecast
See Also
Price Target
Loading...
Revenue
Loading...
Operating Income
Loading...
Net Income
Loading...

Wall Street
Price Targets

LUCD Price Targets Summary
Lucid Diagnostics Inc

Wall Street analysts forecast LUCD stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for LUCD is 3.83 USD with a low forecast of 2.02 USD and a high forecast of 7.88 USD.

LUCD Lowest Forecast
Wall Street Target
2.02 USD
60% Upside
LUCD Average Forecast
Wall Street Target
3.83 USD
204% Upside
LUCD Highest Forecast
Wall Street Target
7.88 USD
525% Upside
Lowest
Price Target
2.02 USD
60% Upside
Average
Price Target
3.83 USD
204% Upside
Highest
Price Target
7.88 USD
525% Upside
Lucid Diagnostics Inc Competitors:
Price Targets
6609
Shanghai HeartCare Medical Technology Corp Ltd
27% Downside
NMTC
Neuroone Medical Technologies Corp
122% Upside
ATRC
AtriCure Inc
57% Upside
6869
Sysmex Corp
40% Upside
6609
Shanghai HeartCare Medical Technology Corp Ltd
27% Downside
NMTC
Neuroone Medical Technologies Corp
122% Upside
ATRC
AtriCure Inc
57% Upside
6869
Sysmex Corp
40% Upside
SOM
Somnomed Ltd
43% Upside
SOON
Sonova Holding AG
4% Upside
M
301363
Mehow Innovative Ltd
56% Upside

Revenue
Forecast

Revenue Estimate
Lucid Diagnostics Inc

The compound annual growth rate of Lucid Diagnostics Inc's revenue for the next 3 years is 115%.

N/A
Past Growth
115%
Estimated Growth
Estimates Accuracy
-5%
Average Miss
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Lucid Diagnostics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
0%
Average Beat
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Lucid Diagnostics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-64%
Average Miss
What are analyst estimates?

See Also

Summary
LUCD intrinsic value, competitors valuation, and company profile.
DCF Valuation
LUCD stock valuation using Discount Cash Flow valuation method.
Relative Valuation
LUCD stock valuation using valuation multiples.
Wall Street Estimates
LUCD price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
LUCD stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is LUCD's stock price target?
Price Target
3.83 USD

According to Wall Street analysts, the average 1-year price target for LUCD is 3.83 USD with a low forecast of 2.02 USD and a high forecast of 7.88 USD.

What is Lucid Diagnostics Inc's Revenue forecast?
Projected CAGR
115%

The compound annual growth rate of Lucid Diagnostics Inc's revenue for the next 3 years is 115%.

Back to Top
ALPHA SPREAD
Follow us
Join more than 255,800+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.